Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Medical Center
Los Angeles, California, United States
- University of Colorado (denver)
Denver, Colorado, United States
- Winship Cancer Institute at Emory Midtown
Atlanta, Georgia, United States
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Iowa Hospitals and Clinic
Iowa City, Iowa, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Hospital
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health & Sciences University
Portland, Oregon, United States
- University of Pittsburg Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- Fred Hutchinson Cancer Research Center/seattle Cancer Care
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Sept 2013
- Completion
- 10 Mar 2017
- Last update posted
- 12 Apr 2017
- Registered enrollment
- 136
- Registry id
- NCT01141491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.